Do differences in age specific androgenic steroid hormone levels account for differing prostate cancer rates between Arabs and Caucasians?

Objective:  Factors responsible for the low incidence of clinical prostate cancer in the Arab population remain unclear, but may be related to differences in androgenic steroid hormone metabolism between Arabs and other populations, especially as prostate cancer is believed to be androgen dependent. We therefore measured the levels of serum androgenic steroids and their binding proteins in Arab men and compared results obtained with values reported for Caucasian populations to determine if any differences could at least partially account for differences in incidence of prostate cancer rates between the two populations.

[1]  D. Schnorr,et al.  Dehydroepiandrosterone (DHEA) levels in patients with prostatic cancer, heart diseases and under surgery stress. , 2009, Experimental and clinical endocrinology.

[2]  R. Lieberman.  Evolving strategies for prostate cancer chemoprevention trials , 2003, World Journal of Urology.

[3]  M. Elmlinger,et al.  Endocrine Alterations in the Aging Male , 2003, Clinical chemistry and laboratory medicine.

[4]  J. Weissfeld,et al.  Testosterone, sex hormone-binding globulin, and body composition in young adult African American and Caucasian men. , 2001, Metabolism: clinical and experimental.

[5]  A. Peracha,et al.  Prostatic carcinoma: a nutritional disease? Conflicting data from the Kingdom of Saudi Arabia. , 2000, The Journal of urology.

[6]  C. Mantzoros,et al.  Hormonal predictors of prostate cancer: a meta-analysis. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  C. Pettaway.  Racial differences in the androgen/androgen receptor pathway in prostate cancer. , 1999, Journal of the National Medical Association.

[8]  O. Shittu,et al.  Increased incidence of prostate cancer in Nigerians. , 1999, Journal of the National Medical Association.

[9]  R. Santen,et al.  Comparative rates of androgen production and metabolism in Caucasian and Chinese subjects. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  J. Ferlay,et al.  Cancer Incidence in Five Continents , 1970, Union Internationale Contre Le Cancer / International Union against Cancer.

[11]  M. Stampfer,et al.  Prospective study of sex hormone levels and risk of prostate cancer. , 1996, Journal of the National Cancer Institute.

[12]  J. Veldhuis,et al.  Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density--a clinical research center study. , 1995, The Journal of clinical endocrinology and metabolism.

[13]  G. Coetzee,et al.  Does the racial‐ethnic variation in prostate cancer risk have a hormonal basis? , 1995 .

[14]  J. Goméz,et al.  Changes in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men. , 1994, The Journal of clinical endocrinology and metabolism.

[15]  K. Pienta,et al.  Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. , 1994, Urology.

[16]  N. Ling,et al.  Human plasma free activin and inhibin levels during the menstrual cycle. , 1993, The Journal of clinical endocrinology and metabolism.

[17]  M. Pike,et al.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males , 1992, The Lancet.

[18]  H. Nyborg,et al.  Racial/ethnic variations in male testosterone levels: A probable contributor to group differences in health , 1992, Steroids.

[19]  R. Santen,et al.  Clinical and biochemical parameters of androgen action in normal healthy Caucasian versus Chinese subjects. , 1991, The Journal of clinical endocrinology and metabolism.

[20]  A. Kitabchi,et al.  Divergent correlations of circulating dehydroepiandrosterone sulfate and testosterone with insulin levels and insulin receptor binding. , 1988, The Journal of clinical endocrinology and metabolism.

[21]  C. Petitclerc,et al.  Approved recommendation (1987) on the theory of reference values. Part 2. Selection of individuals for the production of reference values , 1987 .

[22]  D. West,et al.  Quantitating genetic and nongenetic factors that determine plasma sex steroid variation in normal male twins. , 1986, Metabolism: clinical and experimental.

[23]  J. Lobotsky,et al.  Plasma testosterone and urinary 17-ketosteroids in Japanese and occidentals. , 1966, The Journal of clinical endocrinology and metabolism.

[24]  D. Osegbe.  Prostate cancer in Nigerians: facts and nonfacts. , 1997, The Journal of urology.

[25]  F. Angwafo,et al.  Is cancer of the prostate rare in tropical (black) Africa? Case series from the Centre Hospitalier et Universitaire and the Hospital General de Yaounde from 1986 to 1990. , 1994, Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique.

[26]  L. Kolonel,et al.  Prostate cancer: a current perspective. , 1991, Epidemiologic reviews.

[27]  L. Bernstein,et al.  Serum testosterone levels in healthy young black and white men. , 1986, Journal of the National Cancer Institute.